Remove Access Remove Clinical Trials Remove Workshop
article thumbnail

TGA – Australia: Independent Expert Panel on MDMA and psilocybin – Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions

Cannabis Law Report

The review excludes pre-clinical trials (i.e. Given our increasing mental health emergency, equitable access to these treatments has never been more important. You can see the program and get your Summit and workshop tickets here >> experimental pharmacology studies in test tube or animal models).

article thumbnail

Silo Wellness And Kaivalya Kollectiv Announce Psychedelic Retreats

SpeedWeed

Under the newly announced partnership, Silo Wellness will operate two 5-MeO-DMT retreats in Jamaica, where the company already conducts psilocybin-assisted retreats and mushroom and truffle cultivation workshops. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What’s Next for the NIH When it Comes to Psychedelics?

Veriheal

Collins responded that they have made “some progress” but that the schedule 1 listing of the substances causes researchers to have to “overcome significant hurdles to access it”. . However, it is challenging to do this as the scheduling of substances stands in the way of accessing them- even if allocations have been made to do so. .

article thumbnail

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

This shift can be attributed to increased access to information, a more liberal societal outlook, and a willingness to explore alternative healthcare options. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ingmargorman/ [link]. in/spencer-hawkswell-210a8189/ [link]. in/psilocybin/ [link].